{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T22:24:14Z","timestamp":1759616654929,"version":"3.41.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003069","name":"Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","neuropeptidesjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.npep.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T22:05:56Z","timestamp":1507845956000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Analgesic and anxiolytic effects of [Leu 31 ,Pro 34 ]-neuropeptide Y microinjected into the periaqueductal gray in rats"],"prefix":"10.1016","volume":"66","author":[{"given":"Priscila","family":"V\u00e1zquez-Le\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Mendoza-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Ram\u00edrez-San","family":"Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German Alberto","family":"Chamorro-Cevallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Miranda-P\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2017.10.001_bb0005","first-page":"550","article-title":"Human tonic immobility: measurement and correlates","volume":"26","author":"Abrams","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.npep.2017.10.001_bb0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/306584a0","article-title":"Neuropeptide Y distribution in human brain","volume":"306","author":"Adrian","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.npep.2017.10.001_bb0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.6136091","article-title":"Neuropeptide Y distribution in the rat brain","volume":"221","author":"Allen","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.npep.2017.10.001_bb0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.physbeh.2006.12.015","article-title":"Ontogenic interaction between social relationships and defensive burying behavior in rat","volume":"90","author":"Arakawa","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.npep.2017.10.001_bb0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cne.901870304","article-title":"The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies on the anatomy of pain modulation","volume":"187","author":"Basbaum","year":"1979","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2017.10.001_bb0030","series-title":"The Rat Nervous System","first-page":"173","article-title":"Periaqueductal gray","author":"Beitz","year":"1994"},{"issue":"5","key":"10.1016\/j.npep.2017.10.001_bb0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.physbeh.2012.03.004","article-title":"Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y","volume":"107","author":"Bowers","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.npep.2017.10.001_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2007.10.018","article-title":"Different patterns of freezing behavior organized in the periaqueductal gray of rats: Association with different types of anxiety","volume":"188","author":"Brand\u00e3o","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/00008877-199504000-00001","article-title":"Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear potentiated startle procedures","volume":"6","author":"Broqua","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.npep.2017.10.001_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(96)00262-4","article-title":"Antinociceptive effects of neuropeptide Y and related peptides in mice","author":"Broqua","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbr.2012.09.049","article-title":"Temporal structure of the rat's behavior in elevated plus maze test","volume":"237","author":"Casarrubea","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0060","doi-asserted-by":"crossref","unstructured":"Chronwall, B.M., DiMaggio, D.A., Massari, V.J., Pickel, V.M., Ruggiero, D.A., O'Donohue, T.L., 1985. The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15, 1159\u20131181.","DOI":"10.1016\/0306-4522(85)90260-X"},{"key":"10.1016\/j.npep.2017.10.001_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/npp.2011.230","article-title":"The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.npep.2017.10.001_bb0070","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-2826.2008.01772.x","article-title":"Behavioral assays to model cognitive and affective dimensions of depression and anxiety in rats","volume":"20","author":"Danet","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.npep.2017.10.001_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(03)01278-0","article-title":"Defensive burying in rodents: ethology, neurobiology and psychopharmacology","volume":"463","author":"De Boer","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2017.10.001_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00241413","article-title":"Quiescence and hyporeactivity evoked by activation of cells bodies in the ventrolateral midbrain periaqueductal gray of rat","volume":"99","author":"Depaulis","year":"1994","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.npep.2017.10.001_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbr.2007.07.030","article-title":"Electrical stimulation of dorsal but not ventral hippocampus reduces behavioral defense in the elevated plus maze and shock-probe burying test in rats","volume":"186","author":"Dringenberg","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ynstr.2014.09.007","article-title":"Targeting the neuropeptide Y system in stress-related psychiatric disorders","volume":"1","author":"Enman","year":"2015","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.npep.2017.10.001_bb0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2003.10.011","article-title":"Distinct regions of periaqueductal gray (PAG) are involved in freezing behavior in hooded PVG rats on the cat-freezing test apparatus","volume":"354","author":"Farook","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2017.10.001_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jad.2007.07.015","article-title":"Peritraumatic tonic immobility predicts a poor response to pharmacological treatment in victims of urban violence with PTSD","volume":"107","author":"Fiszman","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.npep.2017.10.001_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1073\/pnas.87.1.182","article-title":"[Leu31,Pro34]neuropeptide Y: A specific Y1 receptor agonist","volume":"80","author":"Fuhlendorff","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2017.10.001_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/088626093008001008","article-title":"Victim reactions during rape\/sexual assault: a preliminary study of the immobility response and its correlates","volume":"8","author":"Galliano","year":"1993","journal-title":"J. Interpers. Violence"},{"key":"10.1016\/j.npep.2017.10.001_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.npep.2004.07.002","article-title":"Introduction to the reviews on neuropeptide Y","volume":"38","author":"Gehlert","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.10.001_bb0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbr.2013.09.023","article-title":"Effects of angiotensin (5-8) microinfusions into the ventrolateral periaqueductal gray on defensive behaviors in rats","volume":"256","author":"Genaro","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0024-3205(86)90061-5","article-title":"Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system","volume":"38","author":"Gray","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2017.10.001_bb0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/1056-8719(93)90063-K","article-title":"An assessment of the elevated X-Maze for studying anxiety-modulating drugs","volume":"29","author":"Handley","year":"1993","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.npep.2017.10.001_bb0135","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.brat.2004.08.005","article-title":"Tonic immobility and childhood sexual abuse: a preliminary report evaluating the sequel of rape-induced paralysis","volume":"43","author":"Heidt","year":"2004","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.npep.2017.10.001_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.10.001_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1990.tb01366.x","article-title":"Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses","volume":"82","author":"Heilig","year":"1990","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.npep.2017.10.001_bb0150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.npep.2017.10.001_bb0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.1993.35","article-title":"Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effect","volume":"8","author":"Heilig","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2017.10.001_bb0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0167-0115(98)00076-7","article-title":"Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats","volume":"75-76","author":"Kask","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2017.10.001_bb0165","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1097\/00001756-199808240-00005","article-title":"NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test","volume":"9","author":"Kask","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.npep.2017.10.001_bb0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2017.10.001_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.npep.2004.04.002","article-title":"Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes","volume":"38","author":"Koglin","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.10.001_bb0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","article-title":"Role of neuropeptides in anxiety, stress, and depression: From animals to humans","volume":"47","author":"Kormos","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.10.001_bb0185","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0026-895X(25)09119-9","article-title":"Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor","volume":"41","author":"Krause","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2017.10.001_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.npep.2004.06.002","article-title":"Molecular evolution of NPY receptor subtypes","volume":"38","author":"Larhammar","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.10.001_bb0195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.npep.2017.10.001_bb0200","first-page":"1004","article-title":"Tonic immobility behavior: a model to fear, anxiety or depression","volume":"1","author":"Leite-Panissi","year":"2016","journal-title":"JSM Anxiety Depress"},{"key":"10.1016\/j.npep.2017.10.001_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-8993(02)02594-5","article-title":"Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect","volume":"940","author":"Li","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0210","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1096\/fasebj.2.11.2840317","article-title":"Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms","volume":"2","author":"Limbird","year":"1988","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2017.10.001_bb0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","article-title":"XVI. International Union of Pharmacology. Recommendations for the nomenclature of neuropeptide Y, peptide YY and pancreatic polypeptide receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2017.10.001_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/NIB-140092","article-title":"The effects of orexin A and orexin B on two forms of immobility responses and on analgesia","volume":"5","author":"Miranda","year":"2014","journal-title":"Adv. Neuroimmune. Biol."},{"key":"10.1016\/j.npep.2017.10.001_bb0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pbb.2016.01.002","article-title":"Involvement of opioid and GABA systems in the ventrolateral periaqueductal gray on analgesia associated with tonic immobility","volume":"142","author":"Miranda","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2017.10.001_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yhbeh.2016.12.002","article-title":"Effect of melatonin injection into the periaqueductal gray on antinociception and tonic immobility in male rats","volume":"89","author":"Miranda","year":"2017","journal-title":"Horm. Behav."},{"key":"10.1016\/j.npep.2017.10.001_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0987-7053(03)00009-1","article-title":"The defense system of fear: behavior and neurocirciutry","volume":"33","author":"Misslin","year":"2003","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.npep.2017.10.001_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0006-8993(98)00669-6","article-title":"Immobility and flight associated with antinociception produced by activation of the ventral and lateral\/dorsal regions of the rat periaqueductal gray","volume":"804","author":"Morgan","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/JMN:29:2:109","article-title":"Distribution of NPY Y5-like immunoreactivity in the rat brain","volume":"29","author":"Morin","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.npep.2017.10.001_bb0250","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cne.902900305","article-title":"Neuronal localization of neuropeptide Y gene expression in rat brain","volume":"290","author":"Morris","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2017.10.001_bb0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008877-200207000-00002","article-title":"Tonic immobility in guinea pigs: a behavioural response for detecting an anxiolytic-like effect?","volume":"13","author":"Olsen","year":"2002","journal-title":"Behav. Pharmacol."},{"year":"2014","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.npep.2017.10.001_bb0260"},{"key":"10.1016\/j.npep.2017.10.001_bb0265","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.neuroscience.2009.09.004","article-title":"Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter","volume":"164","author":"Pelegrini-da-Silva","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2017.10.001_bb0270","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.npep.2017.10.001_bb0275","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/S0024-3205(02)02159-8","article-title":"Neuropeptide Y (NPY) and depression: from animal studies to the human condition","volume":"71","author":"Redrobe","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2017.10.001_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.npep.2004.05.006","article-title":"Interactions between NPY and CRF in the amygdala to regulate emotionality","volume":"38","author":"Sajdyk","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.10.001_bb0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-8981(02)00301-7","article-title":"Neuropeptide Y and its receptors as potential therapeutic drug targets","volume":"326","author":"Silva","year":"2002","journal-title":"Clin. Chem. Acta"},{"key":"10.1016\/j.npep.2017.10.001_bb0290","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-8993(94)91556-3","article-title":"Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3","volume":"633","author":"Siuciak","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cne.903500103","article-title":"Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat","volume":"350","author":"Smith","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2017.10.001_bb0300","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.79.18.5485","article-title":"Neuropeptide Y: Complete amino acid sequence of the brain peptide","volume":"79","author":"Tatemoto","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2017.10.001_bb0305","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y \u2013 a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.npep.2017.10.001_bb0310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pain.2006.12.018","article-title":"Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain","volume":"131","author":"Taylor","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.npep.2017.10.001_bb0315","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainres.2007.04.021","article-title":"Involvement of Y5 receptors in neuropeptide Y agonist-induced analgesic-like effect in the rat hot plate test","volume":"1115","author":"Thomsen","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0320","series-title":"The Behavior of the Laboratory Rat. A Handbook with Tests","first-page":"353","article-title":"Defensive burying","author":"Treit","year":"2005"},{"key":"10.1016\/j.npep.2017.10.001_bb0325","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1037\/0735-7044.112.2.379","article-title":"Does the bed nucleus of the stria terminalis mediate fear behaviors?","volume":"112","author":"Treit","year":"1998","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.npep.2017.10.001_bb0330","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.pbb.2011.06.009","article-title":"Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat","volume":"99","author":"Trent","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.npep.2017.10.001_bb0335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.npep.2009.05.003","article-title":"Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic pain rats: Behavioral and neuroanatomical correlates","volume":"43","author":"Upadhya","year":"2009","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.10.001_bb0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biopsycho.2011.06.002","article-title":"Is there tonic immobility in humans? Biological evidence from victims of traumatic stress","volume":"88","author":"Volchan","year":"2011","journal-title":"Biol. Psychol."},{"issue":"1","key":"10.1016\/j.npep.2017.10.001_bb0345","first-page":"79","article-title":"Microinjection of neuropeptide Y into periaqueductal grey produces anti-nociception in rats with mononeuropathy","volume":"56","author":"Wang","year":"2004","journal-title":"Acta Physiol. Sin."},{"key":"10.1016\/j.npep.2017.10.001_bb0350","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0006-8993(99)02408-7","article-title":"Antinociceptive effects induced by intra-periaqueductal grey administration of neuropeptide Y in rats","volume":"859","author":"Wang","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0355","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-8993(00)03279-0","article-title":"Antinociceptive effect of neuropeptide Y in periaqueductal grey in rats with inflammation","volume":"893","author":"Wang","year":"2001","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.npep.2017.10.001_bb0360","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0022-3956(88)90030-1","article-title":"Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively","volume":"22","author":"Widerl\u00f6v","year":"1988","journal-title":"J. Psychol. Res."},{"key":"10.1016\/j.npep.2017.10.001_bb0365","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cne.10823","article-title":"Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry","volume":"464","author":"Wolak","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.npep.2017.10.001_bb0370","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejphar.2012.10.036","article-title":"Neuropeptide Y is analgesic in rats after plantar incision","volume":"698","author":"Yalamuri","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2017.10.001_bb0375","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-0115(00)00165-8","article-title":"Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats","volume":"95","author":"Zhang","year":"2000","journal-title":"Regul. Pept."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917301440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917301440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:46:41Z","timestamp":1750942001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417917301440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":75,"alternative-id":["S0143417917301440"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2017.10.001","relation":{},"ISSN":["0143-4179"],"issn-type":[{"type":"print","value":"0143-4179"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic and anxiolytic effects of [Leu31,Pro34]-neuropeptide Y microinjected into the periaqueductal gray in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}